Abstract

The purpose of this study was to retrospectively characterize outcomes and complications associated with osteochondral allograft transplantation for treating chondral and osteochondral lesions in a group of client-owned dogs with naturally-occurring disease. Records were reviewed for information on signalment, treated joint, underlying pathology (e.g., osteochondritis dissecans; OCD), and type, size, and number of grafts used. Complications were classified as “trivial” if no treatment was provided, “non-surgical” if non-surgical treatment were needed, “minor surgical” if a minor surgical procedure such as pin removal were needed but the graft survived and function was acceptable, or “major” if the graft failed and revision surgery were needed. Outcomes were classified as unacceptable, acceptable, or full function. Thirty-five joints in 33 dogs were treated including nine stifles with lateral femoral condyle (LFC) OCD and 10 stifles with medial femoral condyle (MFC) OCD treated with osteochondral cylinders or “plugs.” There were 16 “complex” procedures of the shoulder, elbow, hip, stifle, and tarsus using custom-cut grafts. In total there were eight trivial complications, one non-surgical complication, two minor surgical complications, and five major complications for a total of 16/35 cases with complications. Accordingly, there were five cases with unacceptable outcomes, all of whom had major complications while the other 30 cases had successful outcomes. Of the 30 cases with successful outcomes, 15 had full function and 15 had acceptable function. Based on these subjective outcome assessments, it appears osteochondral allograft transplantation is a viable treatment option in dogs with focal or complex cartilage defects. However, no conclusions can be made regarding the inferiority or superiority of allograft transplantation in comparison to other treatment options based upon these data.

Highlights

  • Cartilage damage that causes pain or lameness is common in people and dogs, either secondary to osteoarthritis in which case cartilage loss is typically diffuse, or as focal cartilage defects secondary to osteochondrosis, trauma, or athletic injury [1,2,3,4,5,6,7]

  • The purpose of this study was to report data on complications and outcomes associated with osteochondral allograft (OCA) transplantation for treatment of chondral and osteochondral lesions in dogs

  • Since this was a retrospective study without other treatment groups, it is impossible to draw conclusions regarding inferiority or superiority of OCA transplantation in comparison to current treatments

Read more

Summary

Introduction

Cartilage damage that causes pain or lameness is common in people and dogs, either secondary to osteoarthritis in which case cartilage loss is typically diffuse, or as focal cartilage defects secondary to osteochondrosis, trauma, or athletic injury [1,2,3,4,5,6,7]. Osteochondral allograft (OCA) transplantation is a treatment option used in people, which has not been described for use in clinical canine patients [15,16,17,18]. Osteochondral allograft transplantation involves the transfer of viable, termed “fresh,” osteochondral tissue from a deceased tissue donor to a recipient patient to resurface articular defects with intact hyaline articular cartilage [19,20,21]. Blood type and major histocompatibility complex are not criteria for OCA matching because chondrocytes in intact hyaline cartilage are immune-privileged and antigenic marrow elements are sufficiently removed during tissue storage and graft preparation procedures to avoid immune-mediated rejection [20]. Human patients receiving osteochondral allografts do not require immunosuppression

Objectives
Methods
Findings
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.